Aug 7, 2007
ARLINGTON, VA
August 7, 2007
The Food Marketing Institute (FMI) strongly supports the Fair Medicaid Drug Payment Act (S. 1951) and praises Senate Finance Committee Chairman Max Baucus (D-MT) for introducing this measure, along with co-sponsors Senators Thad Cochran (R-MS), Joe Lieberman (I-CT), Blanche Lincoln (D-AR), Trent Lott (R-MS), Pat Roberts (R-KS), Ken Salazar (D-CO) and Gordon Smith (R-OR).
"This legislation will help ensure that Medicaid recipients can continue to obtain low-cost generic prescriptions at thousands of pharmacies across America," said John J. Motley III, FMI senior vice president of government and public affairs. "It will solve the problems created by a misguided regulation that undermines the ability of retailers to serve Medicaid patients. Retail pharmacies now face the deplorable choice of dispensing only high-cost brand name drugs, no longer serving Medicaid patients at all or, in some cases, shuttering their stores."
This legislation would correct a new generic prescription drug reimbursement rule from the Centers of Medicare and Medicaid Services (CMS) that bases reimbursement for generic prescriptions on its new "average manufacturer price" (AMP) formula. Because the CMS formula bases reimbursement on many discounts, rebates and other price reductions that most retailers do not receive, pharmacies are reimbursed less than they pay to purchase these medications.
The Baucus bill would replace the Medicaid AMP payment reductions for generic drugs with a more rational approach to setting reimbursement rates. Specifically, the measure would:
• Base payments on the weighted average AMP calculated only based on prices paid by pharmacies rather then the lowest AMP based on cost reductions available only to some pharmacists and mail order houses.
• Increase the payment rate to 300 percent of the AMP, up from 250 percent under the current regulation.
• Increase the use of generic drugs in the Medicaid program by requiring prior authorization of brand name drugs that have generic alternatives — saving Medicaid and its beneficiaries money.
FMI members operate more than 19,000 pharmacies in their stores nationwide. Many of these locations provide pharmacy services to significant numbers of Medicaid recipients.
Contact:
Bill Greer
(202) 220-0667
wgreer@fmi.org
August 7, 2007
The Food Marketing Institute (FMI) strongly supports the Fair Medicaid Drug Payment Act (S. 1951) and praises Senate Finance Committee Chairman Max Baucus (D-MT) for introducing this measure, along with co-sponsors Senators Thad Cochran (R-MS), Joe Lieberman (I-CT), Blanche Lincoln (D-AR), Trent Lott (R-MS), Pat Roberts (R-KS), Ken Salazar (D-CO) and Gordon Smith (R-OR).
"This legislation will help ensure that Medicaid recipients can continue to obtain low-cost generic prescriptions at thousands of pharmacies across America," said John J. Motley III, FMI senior vice president of government and public affairs. "It will solve the problems created by a misguided regulation that undermines the ability of retailers to serve Medicaid patients. Retail pharmacies now face the deplorable choice of dispensing only high-cost brand name drugs, no longer serving Medicaid patients at all or, in some cases, shuttering their stores."
This legislation would correct a new generic prescription drug reimbursement rule from the Centers of Medicare and Medicaid Services (CMS) that bases reimbursement for generic prescriptions on its new "average manufacturer price" (AMP) formula. Because the CMS formula bases reimbursement on many discounts, rebates and other price reductions that most retailers do not receive, pharmacies are reimbursed less than they pay to purchase these medications.
The Baucus bill would replace the Medicaid AMP payment reductions for generic drugs with a more rational approach to setting reimbursement rates. Specifically, the measure would:
• Base payments on the weighted average AMP calculated only based on prices paid by pharmacies rather then the lowest AMP based on cost reductions available only to some pharmacists and mail order houses.
• Increase the payment rate to 300 percent of the AMP, up from 250 percent under the current regulation.
• Increase the use of generic drugs in the Medicaid program by requiring prior authorization of brand name drugs that have generic alternatives — saving Medicaid and its beneficiaries money.
FMI members operate more than 19,000 pharmacies in their stores nationwide. Many of these locations provide pharmacy services to significant numbers of Medicaid recipients.
Contact:
Bill Greer
(202) 220-0667
wgreer@fmi.org
Industry Topics address your specific area of expertise with resources, reports, events and more.
Our Research covers consumer behavior and retail operation benchmarks so you can make informed business decisions.
Events and Education including online and in-person help you advance your food retail career.
Food Safety training, resources and guidance that help you create a company food safety culture.
Government Affairs work — federal and state — on the latest food industry policy, regulatory and legislative issues.
Get Involved. From industry awards to newsletters and committees, these resources help you take advantage of your membership.
Best practices, guidance documents, infographics, signage and more for the food industry on the COVID-19 pandemic.
